Background
==========

Mutations in the GFPT1 and DPAGT1 genes, which encode enzymes associated with roles in protein N-linked glycosylation, have been recently identified in a rare subgroup of patients with congenital myasthenic syndromes (CMSs). These mutations are inherited in an autosomal recessive pattern, and the mechanism of impaired neuromuscular transmission may be acetylcholine receptor (AChR) deficiency due to impaired (AChR) subunit glycosylation. Aberrant protein glycosylation is also implicated in the development of severe cardiomyopathies in the congenital disorders of glycosylation, although the mechanisms responsible for cardiac involvement are unknown. We investigated whether patients with CMS and GFPT1 or DPAGT1 mutations also had evidence of a cardiac phenotype.

Methods
=======

We performed comprehensive cardiovascular magnetic resonance (CMR) imaging at 1.5T (Avanto, Siemens), 31P spectroscopy at 3T (Tim Trio, Siemens) and echocardiography to evaluate cardiac structure and function in patients with GFPT1 (n = 2) and DPAGT1 (n = 2) mutations. The mean age of the participants was 45 (range 25-57) and two were male.

Results
=======

Electrocardiography was abnormal in all, with abnormal repolarisation and deep S waves (n = 3) or marked left ventricular hypertrophy by voltage criteria (n = 1). Despite normal biventricular volumes and systolic function, GFPT1/DPAGT1 patients demonstrated late gadolinium enhancement suggestive of myocardial fibrosis (n = 4, mean proportion of enhanced myocardium \> 5 SD above individual reference regions 3.2% +/-1.6, Figure [1](#F1){ref-type="fig"}), impaired energetics (n = 2) and diastolic dysfunction (n = 3). No patient had symptoms attributable to cardiovascular disease on structured interview.

![**Representative electrocardiograph demonstrating repolarization abnormalities with inversion of T-waves in inferolateral leads and deep S waves**.](1532-429X-16-S1-P332-1){#F1}

Conclusions
===========

Patients with GFPT1 or DPAGT1 mutations demonstrate a cardiac phenotype including abnormal electrocardiography, myocardial fibrosis, diastolic dysfunction and impaired energetics, despite normal systolic function. These findings may reflect incipient cardiomyopathy due to aberrant cardiac glycoprotein function. The reason for the milder phenotype than is seen many congenital disorders of glycosylation may be greater residual enzyme function as a consequence of a less pathogenic mutation. This study highlights the utility of CMR for the assessment of rare cardiac phenotypes and reinforces the need for cardiac surveillance in patients with undefined or uncharacterised neuromuscular disorders due to glycosylation pathway defects.
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  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                             Patient 1                                     Patient 2                  Patient 3                  Patient 4                         Reference range
  ------------------------------------------ --------------------------------------------- -------------------------- -------------------------- --------------------------------- --------------------
  Age/years                                  57                                            58                         38                         25                                

                                                                                                                                                                                   

  Gender                                     Female                                        Female                     Male                       Male                              

                                                                                                                                                                                   

  Mutation                                   DPAGT1                                        DPAGT1                     GFPT1                      GFPT1                             

                                                                                                                                                                                   

  Nucleotide change                          c.349G \> A\                                  c.478G \> A\               c.44C \> T\                c.1154G \> A\                     
                                             c.699dup                                      c.574G \> A                c.1486C \> T               c.1301G \> A                      

                                                                                                                                                                                   

  Effect on protein                          p.Val117Ile\                                  p.Gly160Ser\               p.Thr15Met\                p.Arg385His\                      
                                             p.Thr234Hisfs\*116                            p.Gly192Ser                p.Arg496Trp                p.Arg434His                       

                                                                                                                                                                                   

  LVEDV/ml                                   104                                           142                        124                        144                               102-218 ml (male)\
                                                                                                                                                                                   83-187 (female

                                                                                                                                                                                   

  LVESV/ml                                   29                                            53                         41                         46                                18-82 ml (male)\
                                                                                                                                                                                   18-66 ml (female)

                                                                                                                                                                                   

  LVEF                                       72                                            63                         67                         68                                57-81%\
                                                                                                                                                                                   (male and female)

                                                                                                                                                                                   

  RVEF                                       75                                            64                         66                         70                                47-71% (male)\
                                                                                                                                                                                   53-73% (female)

                                                                                                                                                                                   

  LV mass/g                                  120                                           115                        134                        124                               81-165 g (male)\
                                                                                                                                                                                   42-150 g (female)

                                                                                                                                                                                   

  LGE regions                                Anterior septum and inferior LV/RV junction   Basal inferolateral wall   Basal inferolateral wall   Inferior and inferolateral wall   

                                                                                                                                                                                   

  LGE \> 5SD/%                               1.6                                           2.3                        5.1                        3.9                               

                                                                                                                                                                                   

  Stress perfusion CMR (visual assessment)   Normal                                        Not performed              Normal                     Normal                            

                                                                                                                                                                                   

  PCr/ATP ratio                              1.19                                          1.01                       2.23                       2.25                              

                                                                                                                                                                                   

  Diastolic function                         Grade 1 dysfunction                           Grade 2 dysfunction        Grade 1 dysfunction        Normal                            
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Baseline characteristics and CMR and echo indices including left ventricular end diastolic volume (LVEDV), left ventricular end systolic volume (LVESV), left ventricular ejection fraction (LVEF), right ventricular ejection fraction (RVEF), late gadolinium enhancement (LGE) and phosphocreatine to adenosine triphosphate ratio (PCrR/ATP).
